Rolence Pharma And ChemicalsLia Bility Partnership Profile
Key Indicators
- Obligation of Contribution ₹ 2.00 Cr
as on 22-01-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.90 Cr
as on 22-01-2024
About Rolence Pharma And ChemicalsLia Bility Partnership
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 2.00 Cr as per MCA.
- CIN/LLPIN/FCRN
AAF-5580
- Incorporation Date
25 Jan 2016
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rolence Pharma And ChemicalsLia Bility Partnership?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramodbhai Kavar  | Designated Partner | 25-Jan-2016 | Current |
| Narayan Chaudhary | Designated Partner | 01-Apr-2021 | Current |
Financial Performance of Rolence Pharma And ChemicalsLia Bility Partnership.
Enhance accessibility to Rolence Pharma And ChemicalsLia Bility Partnership's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rolence Pharma And ChemicalsLia Bility Partnership?
Unlock access to Rolence Pharma And ChemicalsLia Bility Partnership's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹12.90 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 9.01 Cr
- Rajkot Nagarik Sahkari Bank Limited : 3.89 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2023 | Axis Bank Limited | ₹2.00 Cr | Open |
| 19 May 2023 | Axis Bank Limited | ₹2.00 Cr | Open |
| 01 Oct 2022 | Axis Bank Limited | ₹9.10 M | Open |
| 25 Apr 2022 | Axis Bank Limited | ₹3.00 Cr | Open |
| 25 Apr 2022 | Axis Bank Limited | ₹1.10 Cr | Open |
How Many Employees Work at Rolence Pharma And ChemicalsLia Bility Partnership?
Unlock and access historical data on people associated with Rolence Pharma And ChemicalsLia Bility Partnership, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rolence Pharma And ChemicalsLia Bility Partnership, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rolence Pharma And ChemicalsLia Bility Partnership's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
